128 related articles for article (PubMed ID: 32263770)
1. Polymeric nanoparticles for colon cancer therapy: overview and perspectives.
You X; Kang Y; Hollett G; Chen X; Zhao W; Gu Z; Wu J
J Mater Chem B; 2016 Dec; 4(48):7779-7792. PubMed ID: 32263770
[TBL] [Abstract][Full Text] [Related]
2. Targeted nanoparticles for head and neck cancers: overview and perspectives.
Zhao Y; Chen H; Chen X; Hollett G; Gu Z; Wu J; Liu X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Nov; 9(6):. PubMed ID: 28387452
[TBL] [Abstract][Full Text] [Related]
3. Targeted nanoparticles for colorectal cancer.
Cisterna BA; Kamaly N; Choi WI; Tavakkoli A; Farokhzad OC; Vilos C
Nanomedicine (Lond); 2016 Sep; 11(18):2443-56. PubMed ID: 27529192
[TBL] [Abstract][Full Text] [Related]
4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
5. Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides.
Hong ST; Lin H; Wang CS; Chang CH; Lin AM; Yang JC; Lo YL
J Nanobiotechnology; 2019 Aug; 17(1):89. PubMed ID: 31426807
[TBL] [Abstract][Full Text] [Related]
6. Screening for colon cancer: A test for occult blood.
Khakimov N; Khasanova G; Ershova K; Gibadullina L; Vetkina T; Lobisheva G; Chumakova A
Int J Risk Saf Med; 2015; 27 Suppl 1():S110-1. PubMed ID: 26639687
[TBL] [Abstract][Full Text] [Related]
7. Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development.
Piao MY; Cao HL; He NN; Xu MQ; Dong WX; Wang WQ; Wang BM; Zhou B
Scand J Gastroenterol; 2016; 51(5):572-82. PubMed ID: 26691157
[TBL] [Abstract][Full Text] [Related]
8. Colon cancer therapy: recent developments in nanomedicine to improve the efficacy of conventional chemotherapeutic drugs.
Prados J; Melguizo C; Ortiz R; Perazzoli G; Cabeza L; Alvarez PJ; Rodriguez-Serrano F; Aranega A
Anticancer Agents Med Chem; 2013 Oct; 13(8):1204-16. PubMed ID: 23574385
[TBL] [Abstract][Full Text] [Related]
9. Probing the colorectal cancer proteome for biomarkers: Current status and perspectives.
Lee PY; Chin SF; Low TY; Jamal R
J Proteomics; 2018 Sep; 187():93-105. PubMed ID: 29953962
[TBL] [Abstract][Full Text] [Related]
10. Review on the immunotherapy strategies against metastatic colorectal carcinoma.
Signorini L; Delbue S; Ferrante P; Bregni M
Immunotherapy; 2016 Oct; 8(10):1245-61. PubMed ID: 27605072
[TBL] [Abstract][Full Text] [Related]
11. Role of transmembrane glycoprotein mucin 1 (MUC1) in various types of colorectal cancer and therapies: Current research status and updates.
Guo M; You C; Dou J
Biomed Pharmacother; 2018 Nov; 107():1318-1325. PubMed ID: 30257347
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer screening: a global overview of existing programmes.
Schreuders EH; Ruco A; Rabeneck L; Schoen RE; Sung JJ; Young GP; Kuipers EJ
Gut; 2015 Oct; 64(10):1637-49. PubMed ID: 26041752
[TBL] [Abstract][Full Text] [Related]
13. Advances in nanocarriers as drug delivery systems in Chagas disease.
Quijia Quezada C; Azevedo CS; Charneau S; Santana JM; Chorilli M; Carneiro MB; Bastos IMD
Int J Nanomedicine; 2019; 14():6407-6424. PubMed ID: 31496694
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in Polymeric Nanosystems for Treating Cutaneous Melanoma and Its Metastasis.
Chou YP; Lin YK; Chen CH; Fang JY
Curr Pharm Des; 2017; 23(35):5301-5314. PubMed ID: 28699537
[TBL] [Abstract][Full Text] [Related]
15. Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives.
Kahouli I; Tomaro-Duchesneau C; Prakash S
J Med Microbiol; 2013 Aug; 62(Pt 8):1107-1123. PubMed ID: 23558140
[TBL] [Abstract][Full Text] [Related]
16. Increasing colorectal cancer incidence in individuals aged < 50 years-a population-based study.
Gutlic I; Schyman T; Lydrup ML; Buchwald P
Int J Colorectal Dis; 2019 Jul; 34(7):1221-1226. PubMed ID: 31102007
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment.
Afsharzadeh M; Hashemi M; Mokhtarzadeh A; Abnous K; Ramezani M
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1095-1110. PubMed ID: 28954547
[TBL] [Abstract][Full Text] [Related]
18. A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer development.
To KK; Leung WW; Ng SS
Mol Carcinog; 2017 Feb; 56(2):464-477. PubMed ID: 27253631
[TBL] [Abstract][Full Text] [Related]
19. Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer.
Mármol I; Sánchez-de-Diego C; Pradilla Dieste A; Cerrada E; Rodriguez Yoldi MJ
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106826
[TBL] [Abstract][Full Text] [Related]
20. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
Song L; Li Y; He B; Gong Y
Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
